Nobody downloaded yet

Teva Pharmaceuticals: Analyisis - Case Study Example

Comments (0) Cite this document
Summary
Teva Pharmaceuticals: Case Analysis 1. It is evident from the case analysis that innovative product lines are the most potential resources/capabilities of the Teva Pharmaceuticals Industries Ltd according to VRINE criteria. Teva entered innovative drug market in the early 1980s and the company’s strong relationship with Israeli academic institutions added value to its wider market expansion…
Download full paperFile format: .doc, available for editing
GRAB THE BEST PAPER98.6% of users find it useful
Teva Pharmaceuticals: Case Analyisis
Read TextPreview

Extract of sample "Teva Pharmaceuticals: Analyisis"

Download file to see previous pages As the company extremely relied on external institutions for drug discovery, they could develop highly effective drugs at relatively lower costs. Therefore, it was a difficult task for the rival firms to develop substitutable drugs that possess competitive advantages over Teva’s drugs. In addition, the external assistance for drug research and development assisted Teva to launch drugs that could not be easily imitated by others. Since the Teva’s drugs had distinctive advantages over the competitors’ products, it dominated different market segments and millions of consumers. Potential employee groups are other potential resources of Teva pharmaceuticals. From the case study, it is obvious that the company has a good will for its fair employee retention. The exhibit 4 clearly reflects that the Teva possessed more number of employees than any other competitor did (Khanna, Palepu and Madras, 20). The higher employee potential aided the company to easily deal with its market expansion process and thereby to add value to the firm’s profitability. As Teva was a well established company with a good range of potential product lines, they had the strong financial background to employ enough human resources. However, the firm’s potential competitors including Sandoza, Ranbaxy, and Dr. Reddy’s had not the financial capacity to appoint such a large volume of employees. Moreover, the good financial background and reputation benefited Teva to recruit highly efficient and skilled employees. While assessing the history of the Teva, it is clear that employees played an inevitable role in lifting the company to the current position. 2. In order to assess the long term sustainability of Teva pharmaceuticals, it would be better to analyze the company using the Porter’s Five Forces model. Threat of new entrants While analyzing the pharmaceutical industry, it seems that Teva does not face threats of new market entrants. Financial as well as intangible barriers ranging from higher fixed costs to extreme intellectual property protection regulations raise potential challenges to new entrants. In addition, new entrants are forced to spend heavy budget on research and development for the troublesome process of drug discovery and manufacture. Moreover, they need to attain the approval of various regulatory bodies including Food and Drug Administration (FDA) in the Unites States. Threat of substitutes Until the mid 1980s, there were no substitutes for the medications prescribed by a physician as a result of stringent drug replication regulations. Currently, the Teva pharmaceuticals is greatly threatened by substitutes since a large number of companies sell their drugs after a single name. Therefore, when a patient reaches the medical shop with the prescription, pharmacists tend to give him a cheaper drug of the similar name or another company’s medicine in order for taking financial benefits. This situation can threaten the business sustainability of Teva. Supplier power The case study clearly says that Teva is one of the leading players in the pharmaceuticals industry. As we discussed earlier, the company maintained strong business relationship with the key players in the industry including Israeli academic institutions and Weizmann. It enabled the company to obtain raw materials and other supplies at moderate costs by ...Download file to see next pagesRead More
Cite this document
  • APA
  • MLA
  • CHICAGO
(“Teva Pharmaceuticals: Case Analyisis Study Example | Topics and Well Written Essays - 1000 words”, n.d.)
Teva Pharmaceuticals: Case Analyisis Study Example | Topics and Well Written Essays - 1000 words. Retrieved from https://studentshare.org/business/1433566-teva
(Teva Pharmaceuticals: Case Analyisis Study Example | Topics and Well Written Essays - 1000 Words)
Teva Pharmaceuticals: Case Analyisis Study Example | Topics and Well Written Essays - 1000 Words. https://studentshare.org/business/1433566-teva.
“Teva Pharmaceuticals: Case Analyisis Study Example | Topics and Well Written Essays - 1000 Words”, n.d. https://studentshare.org/business/1433566-teva.
  • Cited: 0 times
Comments (0)
Click to create a comment or rate a document

CHECK THESE SAMPLES OF Teva Pharmaceuticals: Case Analyisis

New Pharmaceuticals

...?Describe the steps that are required to bring a new pharmaceutical to market. The process of introduction of a new drug into market starts from the New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) as part of the regulation and control of new drugs in the United States since 1938. The NDA involves submission of data collected from animal experiment studies and human clinical trials for the Investigational New Drug (IND) by the sponsors who wish to be licensed for manufacturing and marketing the new drug proposed. The FDA examines the NDA from the data submitted by the applicant company whether the drug proposed is safe and effective in curing the ailments as claimed besides ensuring that the...
3 Pages(750 words)Essay

Lorex Pharmaceuticals

...Quantitative Case Analysis: Lorex Pharmaceuticals Executive Summary Lorex Pharmaceuticals has developed and holds all patent rights to Linatol, a new high blood pressure medicine. Since the pharmaceutical industry operates in a monopolistically competitive atmosphere (where no specific pharmaceutical company dominates the market), the patent-holder of a new product can have considerable market advantage over other companies. Lorex pharmaceutical is therefore seeking solutions to optimize this competitive advantage by balancing cost, productivity, and quality with regards to the production of Linatol. To reach this end, the managers of...
5 Pages(1250 words)Essay

Patending of Pharmaceuticals Conflicts

...the effect of the natural ligand, or to block the receptor-ligand interaction, whichever is desired. In practice the reality has not matched the promise. The other two methods exploit the fact that it is now possible to do initial screening assays very rapidly and with very small amounts of many compounds, the entire process being fully automated. The problem is to find enough test compounds to put into the assays. One way is to randomly screen large groups of samples which may be compounds from non-pharmaceutical sources, for example compounds originally synthesized as photographic chemicals, or may be from natural sources. In the latter case the samples need not be pure compounds; they may be plant...
20 Pages(5000 words)Essay

Financial Plan ABC Pharmaceuticals

...Financial Plan ABC Pharmaceuticals February 10, 2007 CONTENTS EXECUTIVE SUMMARY 3 SECTION ONE 4 About MPMP 4 Resource Planning for MPMP 4 Budget Allocation for MPMP 5 Funding Options for MPMP 7 SECTION TWO 12 Cash Flow Forecast 12 Profit & Loss and Trading Forecast 14 Projected Capital Expenditure 16 Sensitivity Analysis 16 BIBLIOGRAPHY 18 EXECUTIVE SUMMARY ABC Pharmaceuticals is a leading pharmaceuticals company that applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs that target current unmet and underserved medical need of its target market. The current product range of ABC comprises severe pain medication market...
12 Pages(3000 words)Essay

A case study Teva Pharmaceutical Industries, Ltd

...A case study Teva Pharmaceutical Industries, Ltd. Summary and problems Israel was one of the largest consumer markets for the American products (Brinerman). With the international trade, Israel had the opportunity of making relationship with U.S. and European countries. The Teva Pharmaceutical was the first and the biggest company to enter into the U.S. and European markets to enhance their geographical reach for their marketing business. Teva was the world’s biggest producer of generic pharmaceuticals. Avoiding the traditional conglomerate model, Teva became the country’s largest public company and a...
5 Pages(1250 words)Essay

Comparative analyisis

...College Introduction Human nature is to keep looking for solutions with the different challenges they do face, both at their work place and in social life alike. Most of the research has been done by philosophers, scientific research, and Medical researchers have spent sleepless nights to get solutions to the many problems facing human race (Wilmut,2007). There has been a cleavage in the paradigm ideology, and the intellectuals in the field of Science and ethics. This paper will tackle issue as discussed by these two critical thinkers Conley and Professor Ian Wilmut on the issue of human cloning. Conley comes out with a harsh and firm tone that human cloning should not be practiced as it does interfere with God’s creation... Introduction...
3 Pages(750 words)Essay

Company case study and Industry analyisis

...Company Case Study and Industry Analysis This paper aims to present the Fast Food Industry Analysis in association with KFC which is one of the leading fast food chains of the world. KFC is operating under the parent company YUM! Brands. Initially KFC was established by Colonel Sanders who was an American expert in cooking. Due to the poor financial condition of his family he started cooking at a very young age and gained immense experience. Later in life he started a food chain which turned out to be very successful and named as KFC. The company was performing well and therefore it was bought by PepsiCo. This paper has discussed the history and outlook of the company along with a deep analysis of the over Fast Food...
8 Pages(2000 words)Research Paper

Pfizer Pharmaceuticals

...How the macro economy helping to promote growth Pharmaceutical Industry in France From a macroeconomic standpoint, standardization straightforwardly helps the growth in the French economy. (MIOTTI, 2009) Standardization helps a normal of 0.81% for every year, or just about 25% of GDP growth. (MIOTTI, 2009) This is in accordance with figures for other technological heading nations, for example, Germany and the United Kingdom. (MIOTTI, 2009)The second of these measurements is microeconomics. (MIOTTI, 2009). And this is definitely what makes this study novel. This is an in-profundity study of 1,790 organizations or associations of all sizes and from all areas of action, independent of whether they are included in the...
3 Pages(750 words)Research Paper

Israel and the Teva Company

...Teva Case Study Teva Case Study Question Israel gave Teva a serene environment for growth and development. Many of the countrieshave been focusing on the returns made by the company. Therefore, laws are enacted in order to increase the taxes being remitted by the companies. These laws prevent the growth of the companies because majority of the firm’s returns are used to pay taxes instead of being used in expanding the business. However, this was not the case with Israel. The country has been focusing on diversifying its source of revenues. This is through expanding other sectors of economy in order to diversify the sources of revenue....
2 Pages(500 words)Assignment

Teva and Sandoz court case

...Case Study Teva Pharmaceuticals Inc V. Sandoz of the case Teva pharmaceuticals Inc owned a patent that entailed manufacturing method of multiple sclerosis drug Copaxone and Sandoz tried marketing a generic version of the drug. Teva was suing for copyright infringement, but Sandoz argued that patent was invalid as it did not outline which method was used in calculation of the molecular weight. The case at the Supreme Court involved the question of whether the US Court of Appeals for Federal Circuit should review a fresh the defense provided at the district Court judgment for ‘clear error’. Facts of the...
4 Pages(1000 words)Case Study
sponsored ads
We use cookies to create the best experience for you. Keep on browsing if you are OK with that, or find out how to manage cookies.

Let us find you another Case Study on topic Teva Pharmaceuticals: Case Analyisis for FREE!

Contact Us